questionsmedicales.fr
Phénomènes génétiques
Structures génétiques
Génome
Composants de génome
Gènes
Exons VDJ
Exons VDJ : Questions médicales fréquentes
Termes MeSH sélectionnés :
Single-Cell Gene Expression Analysis
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Exons VDJ : Questions médicales les plus fréquentes",
"headline": "Exons VDJ : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Exons VDJ : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-17",
"dateModified": "2025-04-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Exons VDJ"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Gènes",
"url": "https://questionsmedicales.fr/mesh/D005796",
"about": {
"@type": "MedicalCondition",
"name": "Gènes",
"code": {
"@type": "MedicalCode",
"code": "D005796",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Exons VDJ",
"alternateName": "VDJ Exons",
"code": {
"@type": "MedicalCode",
"code": "D050441",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Feng Wang",
"url": "https://questionsmedicales.fr/author/Feng%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Laboratory Medicine, Ningbo Medical Center Lihuili Hospital, Ningbo 315040, Zhejiang, China."
}
},
{
"@type": "Person",
"name": "Sai Wang",
"url": "https://questionsmedicales.fr/author/Sai%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Nephrology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, China."
}
},
{
"@type": "Person",
"name": "Yue Han",
"url": "https://questionsmedicales.fr/author/Yue%20Han",
"affiliation": {
"@type": "Organization",
"name": "Department of Nephrology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, China."
}
},
{
"@type": "Person",
"name": "Leping Shao",
"url": "https://questionsmedicales.fr/author/Leping%20Shao",
"affiliation": {
"@type": "Organization",
"name": "Department of Nephrology, The Affiliated Qingdao Municipal Hospital of Qingdao University, Qingdao, China."
}
},
{
"@type": "Person",
"name": "Mateusz Kaduk",
"url": "https://questionsmedicales.fr/author/Mateusz%20Kaduk",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Meta-analysis of single-cell and single-nucleus transcriptomics reveals kidney cell type consensus signatures.",
"datePublished": "2023-06-06",
"url": "https://questionsmedicales.fr/article/37280226",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41597-023-02209-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Single-cell transcriptome analysis upon ECM-remodeling meningioma cells.",
"datePublished": "2024-03-16",
"url": "https://questionsmedicales.fr/article/38491247",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10143-024-02349-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Single-cell transcriptome analysis reveals immune microenvironment changes and insights into the transition from DCIS to IDC with associated prognostic genes.",
"datePublished": "2024-10-03",
"url": "https://questionsmedicales.fr/article/39363164",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12967-024-05706-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Integrative single-cell RNA-seq analysis of vascularized cerebral organoids.",
"datePublished": "2023-11-09",
"url": "https://questionsmedicales.fr/article/37940920",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12915-023-01711-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Single-cell transcriptome analysis of NEUROG3+ cells during pancreatic endocrine differentiation with small molecules.",
"datePublished": "2023-04-25",
"url": "https://questionsmedicales.fr/article/37098639",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13287-023-03338-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Génome",
"item": "https://questionsmedicales.fr/mesh/D016678"
},
{
"@type": "ListItem",
"position": 5,
"name": "Composants de génome",
"item": "https://questionsmedicales.fr/mesh/D040481"
},
{
"@type": "ListItem",
"position": 6,
"name": "Gènes",
"item": "https://questionsmedicales.fr/mesh/D005796"
},
{
"@type": "ListItem",
"position": 7,
"name": "Exons VDJ",
"item": "https://questionsmedicales.fr/mesh/D050441"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Exons VDJ - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Exons VDJ",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Exons VDJ",
"description": "Comment diagnostiquer une anomalie des exons VDJ ?\nQuels tests sont utilisés pour les exons VDJ ?\nLes exons VDJ peuvent-ils être détectés par imagerie ?\nQuels marqueurs indiquent des problèmes avec les exons VDJ ?\nLes tests génétiques sont-ils fiables pour les exons VDJ ?",
"url": "https://questionsmedicales.fr/mesh/D050441?mesh_terms=Single-Cell+Gene+Expression+Analysis&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Exons VDJ",
"description": "Quels symptômes sont liés aux anomalies des exons VDJ ?\nLes symptômes varient-ils selon le type d'anomalie VDJ ?\nLes anomalies VDJ causent-elles des douleurs ?\nPeut-on avoir des symptômes sans anomalie VDJ ?\nLes symptômes des anomalies VDJ sont-ils spécifiques ?",
"url": "https://questionsmedicales.fr/mesh/D050441?mesh_terms=Single-Cell+Gene+Expression+Analysis&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Exons VDJ",
"description": "Peut-on prévenir les anomalies des exons VDJ ?\nLes vaccinations aident-elles à prévenir les complications ?\nUn mode de vie sain peut-il réduire les risques ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nLes conseils génétiques sont-ils utiles pour les familles ?",
"url": "https://questionsmedicales.fr/mesh/D050441?mesh_terms=Single-Cell+Gene+Expression+Analysis&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Exons VDJ",
"description": "Quels traitements existent pour les anomalies VDJ ?\nLa thérapie génique est-elle une option pour les anomalies VDJ ?\nLes antibiotiques sont-ils efficaces contre les anomalies VDJ ?\nLes traitements sont-ils personnalisés pour les anomalies VDJ ?\nLes patients ont-ils besoin de suivi après traitement des anomalies VDJ ?",
"url": "https://questionsmedicales.fr/mesh/D050441?mesh_terms=Single-Cell+Gene+Expression+Analysis&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Exons VDJ",
"description": "Quelles complications peuvent survenir avec les anomalies VDJ ?\nLes anomalies VDJ augmentent-elles le risque de cancer ?\nLes complications sont-elles réversibles ?\nLes patients doivent-ils surveiller des signes de complications ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D050441?mesh_terms=Single-Cell+Gene+Expression+Analysis&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Exons VDJ",
"description": "Quels sont les facteurs de risque pour les anomalies VDJ ?\nL'âge influence-t-il le risque d'anomalies VDJ ?\nLes infections virales augmentent-elles le risque ?\nLe sexe joue-t-il un rôle dans les anomalies VDJ ?\nLes facteurs environnementaux influencent-ils les anomalies VDJ ?",
"url": "https://questionsmedicales.fr/mesh/D050441?mesh_terms=Single-Cell+Gene+Expression+Analysis&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des exons VDJ ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par séquençage de l'ADN et analyse des réarrangements génétiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les exons VDJ ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR et le séquençage sont couramment utilisés pour évaluer les exons VDJ."
}
},
{
"@type": "Question",
"name": "Les exons VDJ peuvent-ils être détectés par imagerie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les exons VDJ nécessitent des analyses moléculaires, pas d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels marqueurs indiquent des problèmes avec les exons VDJ ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux d'anticorps ou des réarrangements génétiques peuvent indiquer des problèmes."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils fiables pour les exons VDJ ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques sont très fiables pour détecter les anomalies des exons VDJ."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux anomalies des exons VDJ ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anomalies peuvent entraîner des infections fréquentes et des troubles immunitaires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type d'anomalie VDJ ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon la nature et la gravité de l'anomalie."
}
},
{
"@type": "Question",
"name": "Les anomalies VDJ causent-elles des douleurs ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anomalies VDJ ne causent généralement pas de douleurs, mais des infections peuvent en provoquer."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans anomalie VDJ ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, d'autres troubles immunitaires peuvent provoquer des symptômes similaires sans anomalies VDJ."
}
},
{
"@type": "Question",
"name": "Les symptômes des anomalies VDJ sont-ils spécifiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils ne sont pas spécifiques et peuvent ressembler à d'autres troubles immunitaires."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies des exons VDJ ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique pour les anomalies des exons VDJ."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à prévenir les complications ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent aider à prévenir les infections chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Un mode de vie sain peut-il réduire les risques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut renforcer le système immunitaire, mais ne prévient pas les anomalies VDJ."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider à la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier les risques et permettre une surveillance précoce."
}
},
{
"@type": "Question",
"name": "Les conseils génétiques sont-ils utiles pour les familles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les conseils génétiques peuvent aider les familles à comprendre les risques d'anomalies VDJ."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les anomalies VDJ ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des thérapies immunosuppressives et des transfusions d'anticorps."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option pour les anomalies VDJ ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais pas encore une option standard pour ces anomalies."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les anomalies VDJ ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques ne traitent pas les anomalies VDJ, mais peuvent traiter les infections secondaires."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés pour les anomalies VDJ ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être personnalisés selon le type et la gravité de l'anomalie."
}
},
{
"@type": "Question",
"name": "Les patients ont-ils besoin de suivi après traitement des anomalies VDJ ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est essentiel pour surveiller les infections et l'immunité."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les anomalies VDJ ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections récurrentes et des troubles auto-immuns."
}
},
{
"@type": "Question",
"name": "Les anomalies VDJ augmentent-elles le risque de cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines anomalies VDJ peuvent augmenter le risque de développer des cancers hématologiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils surveiller des signes de complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance régulière est cruciale pour détecter rapidement les complications."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les anomalies VDJ ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux et des expositions environnementales."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'anomalies VDJ ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines anomalies VDJ sont plus fréquentes chez les jeunes enfants et les adolescents."
}
},
{
"@type": "Question",
"name": "Les infections virales augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections virales peuvent augmenter le risque d'anomalies VDJ."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle dans les anomalies VDJ ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines anomalies peuvent être plus fréquentes chez un sexe que l'autre."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils les anomalies VDJ ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines ou à des radiations peut augmenter le risque d'anomalies."
}
}
]
}
]
}
While the amount of studies involving single-cell or single-nucleus RNA-sequencing technologies grows exponentially within the biomedical research area, the kidney field requires reference transcripto...
Meningiomas are the most common tumours that primarily arise in the central nervous system, but their intratumoural heterogeneity has not yet been thoroughly studied. We aimed to investigate the trans...
Ductal carcinoma in situ (DCIS) of the breast is an early stage of breast cancer, and preventing its progression to invasive ductal carcinoma (IDC) is crucial for the early detection and treatment of ...
We identified eight cell types through cell annotation, finding significant differences in T cell proportions between DCIS and IDC. Using this as a basis, we performed pseudotime analysis on T cell su...
We identified immune cells that may play a role in the progression from DCIS to IDC and uncovered five key genes that can serve as prognostic markers for breast cancer. These findings provide insights...
Cerebral organoids are three-dimensional in vitro cultured brains that mimic the function and structure of the human brain. One of the major challenges for cerebral organoids is the lack of functional...
We integrated single-cell RNA sequencing data of multiple vascularized and vascular organoids and fetal brains from publicly available datasets and assessed the protocol-dependent and culture-day-depe...
This study highlights the current challenges to vascularization strategies in human cerebral organoids and offers a benchmark for the future fabrication of vascularized organoids....
The efficiency of inducing human embryonic stem cells into NEUROG3+ pancreatic endocrine cells is a bottleneck in stem cell therapy for diabetes. To understand the cell properties and fate decisions d...
In this study, we investigated the role of ferroptosis in the tumor microenvironment (TME) of clear cell renal cell carcinoma (ccRCC), the leading cause of renal cancer-related death. We analyzed sing...
Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by hyperandrogenemia of ovarian thecal cell origin, resulting in anovulation/oligo-ovulation and infertility. Our previous...
The cornea is a transparent and avascular tissue located in front of the eye. Its inner surface is lined by a monolayer of corneal endothelial cells (CECs), which maintain the cornea transparency. CEC...
Mesenchymal stromal cells (MSCs) are recognized as a potential cell-based therapy for regenerative medicine. Short-term inflammatory cytokine pre-stimulation (cytokine priming) is a promising approach...
In this study, by analyzing the single-cell transcriptomic landscape of human bone marrow MSCs from a naïve to cytokine-primed state, we elucidated the potential mechanism of superior therapeutic pote...
We found that cytokine-primed MSCs had a distinct transcriptome landscape. Although substantial heterogeneity was identified within the population in both naïve and primed states, cytokine priming enh...
In conclusion, our results provide new insights into MSC heterogeneity under cytokine stimulation and suggest that cytokine priming reprogrammed MSCs independent of heterogeneity....
Peripheral blood mononuclear cells (PBMCs) are widely used as a model in the study of different human diseases. There is often a time delay from blood collection to PBMC isolation during the sampling ...
This study examined the impact of different time periods from blood draw to PBMC isolation on the subsequent transcriptome profiling of different cell types in PBMCs by scRNAseq using the 10X Chromium...
Examining the five major cell types constituting the PBMC cell population, i.e., CD4+ T cells, CD8+ T cells, NK cells, monocytes, and B cells, both common changes and cell-type-specific changes were o...
Significant transcriptome changes were observed across different PBMC cell types as a factor of time from blood draw to PBMC isolation and as a consequence of blood storage. This should be kept in min...
